Medical Devices: Technological Innovation and Patient/Provider Perspectives: Hearing Before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, First Session, May 30, 1997
U.S. Government Printing Office, 1997 - Political Science - 86 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
agency Alpert applications approval process Barton benefit Bilbray Bilirakis brain breast cancer breast implants Burlington Burr cadaver skin CDRH Chairman clinical trials committee Congress consumers Deep Brain Stimulation Dermagraft-TC developed diagnosis DIANA DeGETTE doctors dopamine dramatic Eshoo evaluation FDA reform FDA's fibroblasts Friedman Ganske globus pallidus going Hansbrough hearing heart HUGH DOWNS implantable defibrillator important improve innovative issue labeling lesion levodopa look mammograms mammography manufacturers medical device industry medical devices national uniformity OTC drugs OTC switch pacemaker pallidotomy Pap smears Parkinson's disease patients PDUFA percent physicians premarket approval Prepared Statement prescription drugs problems procedure question radiologists regulation regulatory require risk safe and effective safety stents studies Stupak subcommittee surgery surgical switch drugs testimony therapy things tients tion tissue treatment user fees Vaas Warren Olanow Waxman Whitfield